July 8, 2025 6:30 PM
Novartis wins approval for first malaria drug for newborns and babies
Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies and very young children. Eight African countries who participated in the assessment are now expected to issue quick approvals for the treatment, which is also known as Riamet Baby in some countries. Novartis launched Coartem to treat malaria in 1999, with a new dose strength now designed for small babies. The treatment was developed with scientific and...